Table 2.
Group and immunogenicity trial in pig by adenovirus vaccines.
| Group | First immunization | Second immunization | Immunization dose | Quantity | Virus strain |
|---|---|---|---|---|---|
| 1 | pac-Ad5-34-GP3 | pac-Ad5-34-GP3 | 1.0 × 108TCID50/2 mL | 5 | NADC34 |
| 2 | pac-Ad5-34-GP5 | pac-Ad5-34-GP5 | 1.0 × 108TCID50/2 mL | 5 | NADC34 |
| 3 | pac-Ad5-34-GP35 | pac-Ad5-34-GP35 | 1.0 × 108TCID50/2 mL | 5 | NADC34 |
| 4 | HP-PRRSV (Inactivated vaccine) | HP-PRRSV (Inactivated vaccine) | 1.0 × 108TCID50/2 mL | 5 | NADC34 |
| 5 | ad-wt | ad-wt | 1.0 × 108TCID50/2 mL | 5 | NADC34 |
| 6 | PBS | PBS | 2 mL | 5 | NADC34 |